Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Q2 Revenues up Sharply

NEW YORK (GenomeWeb News) – WaferGen BioSystems said this week that its revenues for the second quarter rose 12-fold year over year.

The Fremont, Calif.-based company reported total revenues of $246,248 for the three months ended June 30, up from $20,158 a year ago. The uptick resulted from $125,000 in license and royalty revenues in the recently completed quarter, compared to none a year ago. Product revenues increased to $121,248 from $20,158 in the second quarter of 2012.

Net loss rose, however, to $3.2 million, or $.14 per share, from a net loss of $1.3 million, or $.04 per share, a year ago.

Interest expenses in the quarter increased to $1.1 million from $452,512 a year ago, while the gain on revaluation of derivative liabilities decreased to $115,237 from $1.5 million a year ago, the company said.

R&D expenses narrowed 19 percent year over year to $1.3 million from $1.6 million, while SG&A costs increased 33 percent to $1.2 million from $866,115.

WaferGen finished the quarter with $3.0 million in cash and cash equivalents.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.